Hepatitis C virus infection in Nigerians with diabetes mellitus

Nigerian Journal of Clinical Practice

Volumn 11, Issue 2, 2008, Pages 94-99

  Nwokediuko, S C ^a   Oli, J M ^a  

^a UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

Diabetes mellitus; Hepatitis C virus

Indexed keywords

HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; INCIDENCE; MALE; MIDDLE AGED; NIGERIA; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NIGERIA; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 55249108910     PISSN: 11193077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Akinkugbe OO, Akinyanju OO. Final Report National Survey on Non-communicable disease in Nigeria. Fed. Min. of Health, Lagos 1997; 65-68.
2. Imoru M, Eke C, Adegoke A. Prevalence of Hepatitis C Virus (HCV) and Human Immunodefiency Virus (HIV) among blood donors in Kano State, Nigeria. Journal of Medical Laboratory Sciences 2003; 12 (1) : 59-63.
3. Erhabor O, Ejele OA, Nwauche CA. The risk of transfusion-acquired hepatitis C Virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria. Nigerian Journal of Clinical Practice 2006; 9 (1) : 18-21.
4. Koate BBD, Busseri FI, Jeremiah ZA. Seroprevalence of Hepatitis C Virus among blood donors in Rivers State, Nigeria. Transfusion Medicine 2005; 15 (5) : 449-451.
5. Egah DZ, Mandong BM, Iya D, Gomwalk NE, Audu ES, Banwat EB et al. Hepatitis C Virus antibodies among blood donors in Jos, Nigeria. Annals of African Medicine 2004; 3 (1) : 35-37.
6. Mohammed MD. Serum alanine aminotransferase may not be a good surrogate marker of Hepatitis C virus infection. A study of blood donors in University of Maiduguri Teaching Hospital, (UMTH), Maiduguri. Sahel Medical Journal 2004; 7 (3) : 88-91.
7. Gumbert SC, Chopra S. Hepatitis C: a multifaceted disease: Review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-620.
8. Nocente R, Ceccanti M, Bertazzoni G, Cammarota G, Silveri NG, Gasbarrini G. HCV infection and extrahepatic manifestations. Hepatogastroenterology 2003; 50: 1149 1154.
9. Ozyilkan E, Erbas T, Simesk H, Telatar F, Kayhan B, Telatar H. Increased prevalence of hepatitis C virus antibodies in patient with diabetes mellitus. J. Intern Med 1994; 235: 283-284.
10. Gray A, Wreighitt T, Stratton I. M, Alerander GJ, Turner RC, O'Rahilly S. High prevalence of hepatitis C infection in Afro-Caribean patients with type 2 diabetes and abnormal liver function tests. Diabet Med 1995; 12: 244-249.
11. Simo R, Hernandez C, Genesca J, Jardi R, Mesa J. High prevalence of Hepatitis C virus infection in diabetic patients. Diabetes Care 1996; 19: 998-1000.
12. Ryu JK, Lee SB, Hong SJ, Lee S. Association of Chronic Hepatitis C Virus infection and diabetes mellitus in Korean patients. Korean J Intern Med 2001; 16: 18-23.
13. Report of expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183
14. Mason AL, Lau YN, Hoang N, Qian K, Alexander GJM, Xu L et al. Association of Diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29: 328-333.
15. Rudoni S, Petit JM, Bour JB, Aho LS, Castaneda A, Vaillant G, et al. HCV infection and diabetes mellitus: Influence of the use of finger stick devices on nosocomial transmission. Diabetes metab 1999; 25: 502-505.
16. Okan V, Araz M, Aktaran S, Karsligil T, Meran I, Bayraktaroglu Z et al. Increased frequency of HCV but not HBV infection in type 2 diabetic patients in Turkey. Int J Clin Pract 2002; 56: 175-177.
17. World Health Organization. Global database on blood safety. Report 2001-2002. http://www.who.int/blood/safety/GDBS-Reoprt-2001-2002.pdf (accessed July 25, 2006).
18. World Health Organization. Global database on blood safety. Summary Report 1998-1999. Http://www.who.int/blood/safety/globaldatabase/en/sumRep- Englishpdf.
19. World Health Organization. Regional Office for Africa. Blood safety strategy for African region. Http://www.who.int/bls/bloodsafety/GDBS.pdf. (accessed My 25, 2006.)
20. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C Virus infection in the United States. Ann Intern Med 2000; 133: 592-599.
21. Grimbert S, Valensi P, Levy-Marchal C, Perret G, Richardet JP, Raffoux C. High Prevalence of diabetes mellitus with chronic hepatitis C: a case-control study. Gastroenterol Clin Biol 1996; 20: 544-548.
22. Zein NN, Abdukarim AS, Wiesner RH, Egan KS, Persing DH. Prevalence of diabetes mellitus in patients with end stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J. Hepatol 2000; 32: 209-217.
23. Muting D, Wohlgemuth D, Dorsett R. Liver cirrhosis and diabetes mellitus. Geriatrics 1969; 24: 91-99.
24. Petrides AS, Defronzo RA. Glucose and insulin metabolism in cirrhosis. J Hepatol 1989; 30: 649-654.
25. Knobler H, Schihmanter R, Zifrouni A, Fenakel G, Schattner. A. Increased risk of type 2 diabetes in non cirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc 2000; 75: 355-359.
26. Yan FM, Chen AS, Hao F, Zhoa XP, Gu CH, Zhao LB et al. Hepatitis C Virus may infect extrahepatic tissues in patients with hepatitis C. World J Gastroenterol 2002; 6: 805-811.
27. Masini M, Campani D, Boggi U, Menicagli M, Funnel N, Pollera M. et al. Hepatitis C Virus infection and human pancreatic beta cell dysfunction. Diabetes care 2005; 28: 940-941.
28. Hieronimus S, Fredenrich A, Tran A, Benzaken S, Fenichel P. Antibodies to GAD in chronic hepatitis C patients. Diabetes care 1997; 20: 1044.
29. Rozario R, Ramakrishana B. Histopathological study of chronic hepatitis B and C: a comparison of two scoring systems. J Hepatol 2003; 38: 223-229.
30. Castera L, Chouteau P, Hezode C, Zafrani ES, Dhumeaux D, Pawlotsky JM. Hepatitis C Virus-induced hepatocellular steatosis. Am J Gastroenterol 2005; 100: 711-715.
31. Abid K, Pazienza V, de Gottardi A, Rubbia-Brandt L, Conne B, Pugnale P, et al. An invitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation. J Hepatol 2005; 42: 744-751.
32. Camma C, Bruno S, Dimarco V, Di Bona D, Rumi M, Vinci M, et al. Insulin resistance is associated with steatosis in non diabetic patients with genotype 1 chronic hepatitis C. Hepatology 2006; 43: 64-71.
33. Hourigan LF, Macdonald GA, Purdie D, Whitehall VH, Shorthouse C, Clouston A et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999; 29: 1215-1219.